BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 34141614)

  • 1. Using Tumor-Infiltrating Immune Cells and a ceRNA Network Model to Construct a Prognostic Analysis Model of Thyroid Carcinoma.
    Zhang F; Yu X; Lin Z; Wang X; Gao T; Teng D; Teng W
    Front Oncol; 2021; 11():658165. PubMed ID: 34141614
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The construction and analysis of tumor-infiltrating immune cell and ceRNA networks in recurrent soft tissue sarcoma.
    Huang R; Meng T; Chen R; Yan P; Zhang J; Hu P; Zhu X; Yin H; Song D; Huang Z
    Aging (Albany NY); 2019 Nov; 11(22):10116-10143. PubMed ID: 31739284
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The construction and analysis of tumor-infiltrating immune cells and ceRNA networks in metastatic adrenal cortical carcinoma.
    Huang R; Liu Z; Tian T; Song D; Yan P; Yin H; Hu P; Zhu X; Liu Y; Li Z; Meng T; Zhang J; Huang Z
    Biosci Rep; 2020 Mar; 40(3):. PubMed ID: 32175564
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Construction and Analysis of ceRNA Network and Patterns of Immune Infiltration in Mesothelioma With Bone Metastasis.
    Huang R; Wu J; Zheng Z; Wang G; Song D; Yan P; Yin H; Hu P; Zhu X; Wang H; Lv Q; Meng T; Huang Z; Zhang J
    Front Bioeng Biotechnol; 2019; 7():257. PubMed ID: 31681739
    [No Abstract]   [Full Text] [Related]  

  • 5. A construction and comprehensive analysis of ceRNA networks and infiltrating immune cells in papillary renal cell carcinoma.
    Fan Y; Dai F; Yuan M; Wang F; Wu N; Xu M; Bai Y; Liu Y
    Cancer Med; 2021 Nov; 10(22):8192-8209. PubMed ID: 34598322
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Construction and Analysis of ceRNA Network and Patterns of Immune Infiltration in Colon Adenocarcinoma Metastasis.
    Chang Z; Huang R; Fu W; Li J; Ji G; Huang J; Shi W; Yin H; Wang W; Meng T; Huang Z; Wei Q; Qin H
    Front Cell Dev Biol; 2020; 8():688. PubMed ID: 32850813
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tumor Microenvironmental Competitive Endogenous RNA Network and Immune Cells Act as Robust Prognostic Predictor of Acute Myeloid Leukemia.
    Cheng Y; Wang X; Qi P; Liu C; Wang S; Wan Q; Liu Y; Su Y; Jin L; Liu Y; Li C; Sang X; Yang L; Liu C; Duan H; Wang Z
    Front Oncol; 2021; 11():584884. PubMed ID: 33898304
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development of a macrophages-related 4-gene signature and nomogram for the overall survival prediction of hepatocellular carcinoma based on WGCNA and LASSO algorithm.
    Yang Z; Zi Q; Xu K; Wang C; Chi Q
    Int Immunopharmacol; 2021 Jan; 90():107238. PubMed ID: 33316739
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Integrative Analysis of Three Novel Competing Endogenous RNA Biomarkers with a Prognostic Value in Lung Adenocarcinoma.
    Tan J; Wang W; Song B; Song Y; Meng Z
    Biomed Res Int; 2020; 2020():2837906. PubMed ID: 32802839
    [TBL] [Abstract][Full Text] [Related]  

  • 10. KCNN4 may weaken anti-tumor immune response via raising Tregs and diminishing resting mast cells in clear cell renal cell carcinoma.
    Cui Y; Shen T; Xu F; Zhang J; Wang Y; Wu J; Bu H; Fu D; Fang B; Lv H; Wang S; Shi C; Liu B; He H; Tang H; Ge J
    Cancer Cell Int; 2022 Jun; 22(1):211. PubMed ID: 35689211
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Construction and Analysis of Tumor-Infiltrating Immune Cells and ceRNA Networks in Bladder Cancer.
    Jiang A; Liu N; Bai S; Wang J; Gao H; Zheng X; Fu X; Ren M; Zhang X; Tian T; Ruan Z; Yao Y; Liang X
    Front Genet; 2020; 11():605767. PubMed ID: 33391354
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Construction and Comprehensive Analysis of ceRNA Networks and Tumor-Infiltrating Immune Cells in Bone Metastatic Melanoma.
    Huang R; Zeng Z; Li G; Song D; Yan P; Yin H; Hu P; Zhu X; Chang R; Zhang X; Zhang J; Meng T; Huang Z
    Front Genet; 2019; 10():828. PubMed ID: 31608101
    [No Abstract]   [Full Text] [Related]  

  • 13. UBASH3B Is a Novel Prognostic Biomarker and Correlated With Immune Infiltrates in Prostate Cancer.
    Wang Z; Wang Y; Peng M; Yi L
    Front Oncol; 2019; 9():1517. PubMed ID: 32010618
    [No Abstract]   [Full Text] [Related]  

  • 14. Circular RNA-Associated Competing Endogenous RNA Network and Prognostic Nomogram for Patients With Colorectal Cancer.
    Song W; Fu T
    Front Oncol; 2019; 9():1181. PubMed ID: 31781492
    [No Abstract]   [Full Text] [Related]  

  • 15. Construction and analysis of a ceRNA network and patterns of immune infiltration in bladder cancer.
    Fu Y; Sun S; Bi J; Kong C; Yin L
    Transl Androl Urol; 2021 May; 10(5):1939-1955. PubMed ID: 34159075
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Construction of a novel nomogram based on competing endogenous RNAs and tumor-infiltrating immune cells for prognosis prediction in elderly patients with colorectal cancer.
    Tao Z; Li B; Kang C; Wang W; Li X; Du Y
    Discov Oncol; 2023 Jul; 14(1):125. PubMed ID: 37428291
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A Competing Endogenous RNA Network Reveals Novel Potential lncRNA, miRNA, and mRNA Biomarkers in the Prognosis of Human Colon Adenocarcinoma.
    Wang WJ; Li HT; Yu JP; Han XP; Xu ZP; Li YM; Jiao ZY; Liu HB
    J Surg Res; 2019 Mar; 235():22-33. PubMed ID: 30691798
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Construction of a ceRNA Network and Analysis of Tumor Immune Infiltration in Pancreatic Adenocarcinoma.
    Xiao J; Lv C; Xiao C; Ma J; Liao J; Liu T; Du J; Zuo S; Li H; Gu H
    Front Mol Biosci; 2021; 8():745409. PubMed ID: 34760926
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of RNA Expression Profiles in Thyroid Cancer to Construct a Competing Endogenous RNA (ceRNA) Network of mRNAs, Long Noncoding RNAs (lncRNAs), and microRNAs (miRNAs).
    Xu Y; Chen J; Yang Z; Xu L
    Med Sci Monit; 2019 Feb; 25():1140-1154. PubMed ID: 30745559
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comprehensive analyses of competing endogenous RNA networks reveal potential biomarkers for predicting hepatocellular carcinoma recurrence.
    Yan P; Huang Z; Mou T; Luo Y; Liu Y; Zhou B; Cao Z; Wu Z
    BMC Cancer; 2021 Apr; 21(1):436. PubMed ID: 33879119
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.